The FDA Just Rejected a Bid for MDMA to Treat PTSD

The FDA Just Rejected a Bid for MDMA to Treat PTSD

The US Food and Drug Administration has rejected a first-of-its-kind proposal to use the psychedelic drug MDMA, also known as ecstasy or Molly, as a treatment for post-traumatic stress disorder. Drugmaker Lykos Therapeutics had asked the FDA to approve the drug in combination with talk therapy. The company said Friday that the regulatory agency has … Read more

A Pill That Kills Ticks Is a Promising New Weapon Against Lyme Disease

A Pill That Kills Ticks Is a Promising New Weapon Against Lyme Disease

If you have a dog or cat, chances are you’ve given your pet a flavored chewable tablet for tick prevention at some point. What if you could take a similar pill to protect yourself from getting Lyme disease? Tarsus Pharmaceuticals is developing such a pill for humans—minus the tasty flavoring—that could provide protection against the … Read more

Drug regulator tightens sampling norms to test quality of medicines

Drug regulator tightens sampling norms to test quality of medicines

New Delhi: India’s apex drug regulator has come up with new guidelines for sampling of drugs, cosmetics and medical devices amid persistent concerns around the quality of medicines manufactured in the country. Since 2022, drugs made in India and exported to other countries have been under the scanner due to instances of serious adulteration coming to … Read more

‘Can hamper entry of new drugs’ — groups raise alarm over IP proposals part of India-EFTA talks

‘Can hamper entry of new drugs’ — groups raise alarm over IP proposals part of India-EFTA talks

New Delhi: Several organisations working to promote access to life-saving drugs on Wednesday warned if the final text of the India and the European Free Trade Association (EFTA) agreement retained the currently-included “harmful” intellectual property proposals, access to affordable medicines for millions of people around the world may be severely undermined. ThePrint had reported on … Read more

A Study at the Center of the Abortion Pill Battle Was Just Retracted

A Study at the Center of the Abortion Pill Battle Was Just Retracted

Scientific publisher Sage Journals has retracted three papers on abortion—including a controversial 2021 study on mifepristone, the medication at the center of a US legal battle. The 2021 study found that mifepristone, one of two pills used in a medication abortion, significantly increased the risk of women going to the emergency room following an abortion. … Read more

A Startup Has Unlocked a Way to Make Cheap Insulin

A Startup Has Unlocked a Way to Make Cheap Insulin

Now some key patents have expired, and the US Food and Drug Administration has paved the way for biosimilar versions of insulin—so-called because they’re almost identical to another product already on the market. For a product to be biosimilar, it must be highly similar in structure to the original and work just as well in … Read more

A Gel Injected Into the Scrotum Could Be the Next Male Contraceptive

A Gel Injected Into the Scrotum Could Be the Next Male Contraceptive

The purpose of the current trial is to assess the gel’s safety and longevity, not how well it prevents pregnancy. Participants were asked to use a back-up form of birth control while being enrolled in the trial. The gel is designed to dissolve at the end of its lifetime, so the men will be followed … Read more

You Know It’s a Placebo. So Why Does It Still Work?

You Know It’s a Placebo. So Why Does It Still Work?

You booked this doctor’s appointment weeks in advance. You took off work, endured the trip here, filled out paperwork while a cooking show blared from a TV on the wall, and now you’re finally in the inner sanctum, awkwardly perched on an exam table and staring at a jar of tongue depressors. Your doctor comes … Read more

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

New Delhi: A new report by a network of multinational pharma companies and a leading consulting firm has said that the Indian pharmaceutical market should aim to achieve a size of US$130 billion by 2030 and US$450 billion by 2047. India’s pharmaceutical market, as of now, stands at about $50 billion. The report by the … Read more

A Single Infusion of a Gene-Editing Treatment Lowered High Cholesterol

A Single Infusion of a Gene-Editing Treatment Lowered High Cholesterol

In a small initial test in people, researchers have shown that a single infusion of a novel gene-editing treatment can reduce cholesterol, the fatty substance that clogs and hardens arteries over time. The experiment was carried out in 10 participants with an inherited condition that causes extremely high LDL, or “bad,” cholesterol levels, which can … Read more